LINE Lineage Q4 2025 earnings deliver strong upside surprise stock notches modest gains on positive investor reaction SLXN Silexion Therapeutics posts wider than expected Q4 2025 loss shares dip 094 in todays trading Why Valero VLO is trading below its true worth Underperforming 20260508 AVD Am Vanguard posts drastically wider Q3 2025 loss versus analyst estimates on unforeseen cost pressures